Pfizer, BioNTech say Covid-19 vaccine is more than 90% effective, exceeding expert expectations and setting up an EUA submission late this month
For 10 months, the US and the world have wondered and watched and waited for when an effective Covid-19 vaccine will arrive. Pfizer said Monday morning that it has.
The Big Pharma and its partner BioNTech said that, on an interim look, their vaccine was at least 90% effective in preventing symptomatic Covid-19 cases. If the data hold up, it would mean a pandemic inoculation vastly more effective than anticipated throughout 2020, when experts warned that the first vaccines could be as low as 60% or 70% effective and the FDA indicated it was willing to approve jabs that surpassed the 50% mark.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.